Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor
Clicks: 319
ID: 268614
2004
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.9
/100
23 views
23 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The Wnt signaling pathway is aberrantly activated in many tumor types, including those of the prostate, in which beta-catenin accumulates in cell nuclei and acts as a transcriptional coregulator for the androgen receptor. Because activating mutations in the beta-catenin gene are rare in prostate can …
| Reference Key |
h2004canceranalysis
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhu H;Mazor M;Kawano Y;Walker MM;Leung HY;Armstrong K;Waxman J;Kypta RM;; |
| Journal | Cancer research |
| Year | 2004 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Tumor
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
genetic
RNA
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
male
cell line
Receptors
transcription
disease progression
signal transduction
messenger / analysis
cell division
androgen / physiology*
wnt proteins
beta catenin
prostatic neoplasms / metabolism
prostatic neoplasms / pathology*
metribolone / pharmacology
pmid:15520198
doi:10.1158/0008-5472.can-04-2704
hanneng zhu
michal mazor
robert m kypta
cytoskeletal proteins / physiology
glycoproteins / genetics*
glycoproteins / physiology
trans-activators / physiology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.